A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis: Ruxolitinib Cream: Pediatric Maximum-Use Trial: L. S. Gold et al. - Stein Gold, Linda; Bissonnette, Robert; Forman, Seth; Zaenglein, Andrea; Kuo, YuTzu; Angel, Brett; Chen, Xuejun; Kallender, Howard; Paller, Amy S. (American Journal of Clinical Dermatology, 2025)